Last reviewed · How we verify

Lurasidone 20, 40, 60, 80 mg, flexibly dosed

Sumitomo Pharma America, Inc. · Phase 3 active Small molecule

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is a Atypical antipsychotic Small molecule drug developed by Sumitomo Pharma America, Inc.. It is currently in Phase 3 development for Schizophrenia, Bipolar I disorder depression. Also known as: Latuda.

Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors in the brain.

Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors in the brain. Used for Schizophrenia, Bipolar I disorder depression.

At a glance

Generic nameLurasidone 20, 40, 60, 80 mg, flexibly dosed
Also known asLatuda
SponsorSumitomo Pharma America, Inc.
Drug classAtypical antipsychotic
TargetDopamine D2 receptor, Serotonin 5-HT7 receptor
ModalitySmall molecule
Therapeutic areaPsychiatry
PhasePhase 3

Mechanism of action

Lurasidone acts as an antagonist at dopamine D2 receptors and serotonin 5-HT7 receptors, with high binding affinity and selectivity for these targets. This dual mechanism helps regulate neurotransmitter activity implicated in psychotic and mood disorders. The drug has minimal affinity for histamine and muscarinic receptors, which may contribute to a favorable side-effect profile compared to older antipsychotics.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lurasidone 20, 40, 60, 80 mg, flexibly dosed

What is Lurasidone 20, 40, 60, 80 mg, flexibly dosed?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is a Atypical antipsychotic drug developed by Sumitomo Pharma America, Inc., indicated for Schizophrenia, Bipolar I disorder depression.

How does Lurasidone 20, 40, 60, 80 mg, flexibly dosed work?

Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors in the brain.

What is Lurasidone 20, 40, 60, 80 mg, flexibly dosed used for?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is indicated for Schizophrenia, Bipolar I disorder depression.

Who makes Lurasidone 20, 40, 60, 80 mg, flexibly dosed?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is developed by Sumitomo Pharma America, Inc. (see full Sumitomo Pharma America, Inc. pipeline at /company/sumitomo-pharma-america-inc).

Is Lurasidone 20, 40, 60, 80 mg, flexibly dosed also known as anything else?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is also known as Latuda.

What drug class is Lurasidone 20, 40, 60, 80 mg, flexibly dosed in?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed belongs to the Atypical antipsychotic class. See all Atypical antipsychotic drugs at /class/atypical-antipsychotic.

What development phase is Lurasidone 20, 40, 60, 80 mg, flexibly dosed in?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed is in Phase 3.

What are the side effects of Lurasidone 20, 40, 60, 80 mg, flexibly dosed?

Common side effects of Lurasidone 20, 40, 60, 80 mg, flexibly dosed include Akathisia, Somnolence, Parkinsonism, Nausea, Headache, Tremor.

What does Lurasidone 20, 40, 60, 80 mg, flexibly dosed target?

Lurasidone 20, 40, 60, 80 mg, flexibly dosed targets Dopamine D2 receptor, Serotonin 5-HT7 receptor and is a Atypical antipsychotic.

Related